Compare Abbott India with Sanofi India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SANOFI INDIA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SANOFI INDIA ABBOTT INDIA/
SANOFI INDIA
 
P/E (TTM) x 46.7 42.9 108.9% View Chart
P/BV x 15.2 8.7 174.7% View Chart
Dividend Yield % 0.5 1.0 45.2%  

Financials

 ABBOTT INDIA   SANOFI INDIA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
SANOFI INDIA
Dec-18
ABBOTT INDIA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs8,8346,840 129.2%   
Low Rs5,4584,630 117.9%   
Sales per share (Unadj.) Rs1,731.11,203.1 143.9%  
Earnings per share (Unadj.) Rs211.9165.3 128.2%  
Cash flow per share (Unadj.) Rs219.9209.9 104.8%  
Dividends per share (Unadj.) Rs65.0084.00 77.4%  
Dividend yield (eoy) %0.91.5 62.1%  
Book value per share (Unadj.) Rs945.2963.6 98.1%  
Shares outstanding (eoy) m21.2523.03 92.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.8 86.6%   
Avg P/E ratio x33.734.7 97.2%  
P/CF ratio (eoy) x32.527.3 118.9%  
Price / Book Value ratio x7.66.0 127.0%  
Dividend payout %30.750.8 60.3%   
Avg Mkt Cap Rs m151,848132,078 115.0%   
No. of employees `0003.53.3 105.6%   
Total wages/salary Rs m4,3564,068 107.1%   
Avg. sales/employee Rs Th10,555.58,393.8 125.8%   
Avg. wages/employee Rs Th1,249.91,232.4 101.4%   
Avg. net profit/employee Rs Th1,292.21,153.0 112.1%   
INCOME DATA
Net Sales Rs m36,78627,708 132.8%  
Other income Rs m1,133897 126.3%   
Total revenues Rs m37,91928,605 132.6%   
Gross profit Rs m6,0476,235 97.0%  
Depreciation Rs m1691,027 16.5%   
Interest Rs m237 321.4%   
Profit before tax Rs m6,9896,098 114.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4852,292 108.4%   
Profit after tax Rs m4,5033,806 118.3%  
Gross profit margin %16.422.5 73.1%  
Effective tax rate %35.637.6 94.6%   
Net profit margin %12.213.7 89.1%  
BALANCE SHEET DATA
Current assets Rs m27,61015,922 173.4%   
Current liabilities Rs m8,5696,235 137.4%   
Net working cap to sales %51.835.0 148.1%  
Current ratio x3.22.6 126.2%  
Inventory Days Days6064 94.6%  
Debtors Days Days2721 131.3%  
Net fixed assets Rs m1,0577,539 14.0%   
Share capital Rs m213230 92.4%   
"Free" reserves Rs m19,87321,962 90.5%   
Net worth Rs m20,08622,192 90.5%   
Long term debt Rs m00-   
Total assets Rs m29,40929,839 98.6%  
Interest coverage x311.6872.1 35.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.9 134.7%   
Return on assets %15.412.8 120.4%  
Return on equity %22.417.2 130.7%  
Return on capital %34.927.5 126.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3697,587 4.9%   
Fx outflow Rs m4,9187,145 68.8%   
Net fx Rs m-4,549442 -1,029.3%   
CASH FLOW
From Operations Rs m4,9913,739 133.5%  
From Investments Rs m-2,570-731 351.6%  
From Financial Activity Rs m-1,428-1,972 72.4%  
Net Cashflow Rs m9931,036 95.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 7.9 14.4 54.9%  
FIIs % 0.1 14.6 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.5 162.9%  
Shareholders   18,270 15,184 120.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TTK HEALTHCARE  ALEMBIC  DR. REDDYS LAB  ELDER PHARMA  UNICHEM LAB  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plunges 746 Points; Banking & Metal Stocks Bleed(Closing)

Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ORCHID PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS